Enabling and optimizing RAASi therapy in cardio-renal patients by controlling potassium level.

1 May 2017 (15:55 - 16:10)
Organised by:
Add to my library
Congress Presentation Part of: Enabling and optimizing Renin-Angiotensin-Aldosterone-System inhibitors (RAASi) therapy in cardio-renal patients by controlling potassium levels Miscellaneous HFA Premium Access Heart Failure 2017 - 4th World Congress on Acute Heart Failure